Susquehanna International Group’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-41,500
| Closed | -$24.9K | – | 12264 |
|
|
2025
Q3 | $24.9K | Buy |
+41,500
| New | +$19.5K | ﹤0.01% | 12015 |
|
|
2025
Q2 | – | Sell |
-25,100
| Closed | -$12.3K | – | 12591 |
|
|
2025
Q1 | $12.3K | Sell |
25,100
-143,600
| -85% | -$84.6K | ﹤0.01% | 12199 |
|
|
2024
Q4 | $145K | Sell |
168,700
-279,900
| -62% | -$1.75M | ﹤0.01% | 11049 |
|
|
2024
Q3 | $3.81M | Buy |
448,600
+160,300
| +56% | +$945K | ﹤0.01% | 4100 |
|
|
2024
Q2 | $1.35M | Sell |
288,300
-470,400
| -62% | -$2.23M | ﹤0.01% | 5893 |
|
|
2024
Q1 | $5.16M | Buy |
758,700
+674,600
| +802% | +$3.03M | ﹤0.01% | 3590 |
|
|
2023
Q4 | $282K | Sell |
84,100
-230,100
| -73% | -$573K | ﹤0.01% | 9961 |
|
|
2023
Q3 | $782K | Buy |
+314,200
| New | +$518K | ﹤0.01% | 7189 |
|
|
2022
Q3 | – | Sell |
-13,300
| Closed | -$13K | – | 13104 |
|
|
2022
Q2 | $13K | Buy |
+13,300
| New | +$21.8K | ﹤0.01% | 12451 |
|
|
2021
Q4 | – | Sell |
-52,600
| Closed | -$873K | – | 13065 |
|
|
2021
Q3 | $873K | Buy |
52,600
+32,800
| +166% | +$566K | ﹤0.01% | 7921 |
|
|
2021
Q2 | $411K | Buy |
+19,800
| New | +$375K | ﹤0.01% | 10064 |
|
Susquehanna International Group's APLT Position: Q1 2026 in Review
Susquehanna International Group sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 52,692 shares — an estimated $5.27K sold.
Susquehanna International Group first reported a position in APLT in Q3 2020 and held it in 19 quarters. The position peaked at $3.3M in Q1 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.
- Susquehanna International Group reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
- Susquehanna International Group sold 52,692 Applied Therapeutics shares in Q1 2026, an estimated $5.27K.
- Susquehanna International Group first reported a position in Applied Therapeutics in Q3 2020 and held it in 19 quarters.
- Susquehanna International Group's Applied Therapeutics position peaked at $3.3M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.